[
  {
    "Company": "AKITA (Finnadvance)",
    "Model": "Blood-Brain Barrier (BBB) Model",
    "Organs/Tissues": "Human brain microvascular endothelium + astrocytes",
    "Physiological/Pathological": "Physiological BBB (tight barrier); can add inflammation or disease states",
    "Cell Source": "Human brain endothelial cells + astrocytes, optionally pericytes (primary or iPSC-derived)",
    "Multiple Cell Types": "Yes (endothelium + astrocytes minimum)",
    "Stromal Cells": "No traditional stroma; astrocytes act as supporting glia",
    "Tissue-resident Immune": "No by default (microglia optional)",
    "Circulating Immune": "Yes if introduced in flow for transmigration assays",
    "Crosstalk (Multi-tissue)": "No standard, single BBB unit; could link to neuron chip",
    "Air-Liquid Interface": "No (both sides fluid)",
    "Extracellular Matrix": "Yes (coating or thin gel, plus membrane for endothelium)",
    "3D Scaffold": "Partly 3D arrangement (monolayer + glial compartment), not large 3D tissue",
    "Notable Features": "Flow-based shear stress, TEER measurement with AKITA Lid, real-time BBB permeability",
    "Plate/Format (Throughput)": "AKITA plate in 96 or 384 footprint, ~24–96 BBB units per plate (medium/high)",
    "Max Culture Duration": "1–3 weeks, stable barrier possible",
    "Readouts - Live Imaging": "Yes (confocal for junctions, tracer leakage in real time)",
    "Readouts - Supernatant Sampling": "Yes, luminal/abluminal compartments for cytokine or drug analysis",
    "Readouts - Cell Retrieval": "Possible by enzymatic removal from channels",
    "Readouts - Whole Tissue": "Yes (fix in plate for IF on endothelium/astrocytes)",
    "Readouts - TEER": "Yes, built-in with AKITA Lid",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "TEER electrodes only",
    "Dead Volume": "Low (microchannel design)",
    "Perfused": "Yes, via AKITA Wave rocker or unidirectional adapter",
    "Gas Mix Controlled": "Incubator environment (5% CO2)",
    "Real-time Microenvironment Control": "Flow rate adjustable, TEER monitored continuously, compound dosing on the fly",
    "model_availability": "Product-based (AKITA plate + lid + wave); do-it-yourself with provided protocol"
  },
  {
    "Company": "AKITA (Finnadvance)",
    "Model": "Lung/Airway ALI Model",
    "Organs/Tissues": "Human bronchial/alveolar epithelium at air-liquid interface",
    "Physiological/Pathological": "Physiological mucociliary epithelium or diseased (e.g. inflamed, infected)",
    "Cell Source": "Human airway epithelial cells (A549 or primary bronchial cells), optional endothelium",
    "Multiple Cell Types": "Yes if co-culture with endothelium or fibroblasts, but base is single epithelial layer",
    "Stromal Cells": "No by default, can add fibroblasts for advanced model",
    "Tissue-resident Immune": "No by default, can add alveolar macrophages",
    "Circulating Immune": "Possible if endothelial layer is present under flow",
    "Crosstalk (Multi-tissue)": "Not typically, single lung barrier unit",
    "Air-Liquid Interface": "Yes (apical side air, basolateral perfusion)",
    "Extracellular Matrix": "Yes (membrane coated with ECM proteins, or thin gel)",
    "3D Scaffold": "Mostly a 2D monolayer under ALI, though 3D possible with layered structure",
    "Notable Features": "Ciliated epithelium, mucus production, TEER measurement, alveolar or bronchial region under flow",
    "Plate/Format (Throughput)": "AKITA plate (96 or 384) with ~24–96 lung units",
    "Max Culture Duration": "Weeks (2–4+) for full differentiation at ALI",
    "Readouts - Live Imaging": "Yes (IF for ZO-1, cilia, mucus, real-time imaging possible)",
    "Readouts - Supernatant Sampling": "Yes (basolateral medium or apical wash)",
    "Readouts - Cell Retrieval": "Yes (trypsin from membrane, or fix in situ)",
    "Readouts - Whole Tissue": "Yes (immunostaining for cilia, tight junctions)",
    "Readouts - TEER": "Yes, via AKITA Lid for barrier integrity",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No direct, TEER electrodes provided",
    "Dead Volume": "Very low (small fluid volumes, ALI on top)",
    "Perfused": "Yes (basolateral flow, apical air)",
    "Gas Mix Controlled": "Incubator-based, air on top side, 5% CO2 in incubator",
    "Real-time Microenvironment Control": "Flow rate, drug addition, aerosol or droplet on apical side, TEER live read",
    "model_availability": "Product-based, user establishes ALI culture on AKITA plate"
  },
  {
    "Company": "AKITA (Finnadvance)",
    "Model": "Lumen Vascular Network Model",
    "Organs/Tissues": "Perfusable 3D microvessels (human endothelium) in ECM",
    "Physiological/Pathological": "Physiological microvascular bed or diseased (inflammation, tumor vasculature)",
    "Cell Source": "Human endothelial cells (e.g. HUVEC) ± pericytes/fibroblasts for stable network",
    "Multiple Cell Types": "Yes typically endothelium + supportive stromal cells",
    "Stromal Cells": "Yes (fibroblasts, mesenchymal cells to facilitate vessel formation)",
    "Tissue-resident Immune": "No by default, can add immune cells in matrix or flow",
    "Circulating Immune": "Yes if introduced in perfusion to test rolling/adhesion",
    "Crosstalk (Multi-tissue)": "No single chip. Could combine with tumor or organ cells to create vascularized organ model",
    "Air-Liquid Interface": "No, fully fluid-filled channels in 3D gel",
    "Extracellular Matrix": "Yes (collagen/fibrin gel to embed vessel network)",
    "3D Scaffold": "Yes (endothelial tubes in 3D ECM)",
    "Notable Features": "Perfusable 3D vasculature, bidirectional or unidirectional flow, watch cell adhesion",
    "Plate/Format (Throughput)": "AKITA 96 or 384, ~24–96 vascular networks in parallel",
    "Max Culture Duration": "Days to weeks (maintain flow for stable networks)",
    "Readouts - Live Imaging": "Yes (confocal, track vascular morphology, cell infiltration)",
    "Readouts - Supernatant Sampling": "Yes (effluent can be analyzed for secreted factors)",
    "Readouts - Cell Retrieval": "Possible by digesting gel or flushing out cells",
    "Readouts - Whole Tissue": "Yes (fix entire 3D vessel, immunostain for CD31 etc.)",
    "Readouts - TEER": "Not standard for random 3D vessels, do permeability tracer assays instead",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "No, external imaging/tracer methods",
    "Dead Volume": "Low, microchannels with minimal wasted volume",
    "Perfused": "Yes, continuous flow driven by AKITA Wave or adapters",
    "Gas Mix Controlled": "Incubator-based (5% CO2)",
    "Real-time Microenvironment Control": "Flow rate adjustments, injection of cells or drugs in real-time",
    "model_availability": "Product-based kit (AKITA Lumen), user self-assembles vessel networks"
  },
  {
    "Company": "AKITA (Finnadvance)",
    "Model": "Gut (Intestine) Model",
    "Organs/Tissues": "Human intestinal epithelium + endothelium in microfluidic barrier",
    "Physiological/Pathological": "Physiological gut barrier (Caco-2 or primary) for drug absorption; can simulate inflamed or diseased",
    "Cell Source": "Caco-2 (standard) or primary/intestine iPSC cells for epithelium, plus microvascular endothelial cells for basolateral side",
    "Multiple Cell Types": "Yes (intestinal epithelial + endothelial). Goblet/fibroblast optional",
    "Stromal Cells": "Not by default, can add fibroblasts if needed",
    "Tissue-resident Immune": "No, but can add immune cells basolaterally",
    "Circulating Immune": "Yes, if included in endothelial channel flow",
    "Crosstalk (Multi-tissue)": "No single chip; can be linked to other organ chips if desired",
    "Air-Liquid Interface": "No (intestinal lumen fluid on top, endothelial side fluid beneath)",
    "Extracellular Matrix": "Membrane + ECM coating for cell attachment, 3D gel if advanced co-culture",
    "3D Scaffold": "Typically a 2D monolayer, though can incorporate 3D features if desired",
    "Notable Features": "Flow-based Caco-2 permeability test, TEER monitoring, simulates oral drug absorption under shear",
    "Plate/Format (Throughput)": "AKITA plate in 96 or 384 footprint, ~24–96 gut barrier units",
    "Max Culture Duration": "Typically ~2–3 weeks to fully differentiate epithelium, can maintain longer",
    "Readouts - Live Imaging": "Yes (IF for tight junctions, morphological changes)",
    "Readouts - Supernatant Sampling": "Yes (apical or basolateral compartments for drug or biomarker measurement)",
    "Readouts - Cell Retrieval": "Yes, from each side of the membrane after experiment",
    "Readouts - Whole Tissue": "Yes (fix monolayers on chip, stain for ZO-1, etc.)",
    "Readouts - TEER": "Yes, integrated via AKITA Lid",
    "Readouts - MEA": "No",
    "Readouts - Integrated Biosensors": "TEER electrodes only",
    "Dead Volume": "Low microchannel volumes, easy to measure transported drug",
    "Perfused": "Yes (basolateral flow, can be bidirectional or unidirectional)",
    "Gas Mix Controlled": "Standard incubator",
    "Real-time Microenvironment Control": "Flow rate changes, drug additions to apical/luminal side, TEER in real time",
    "model_availability": "Product-based (AKITA kit for gut barrier). Lab builds or runs assays"
  }
]
